期刊文献+

^(131)I和^(99m)Tc-MIBI全身显像联合血清Tg和CEA检测在分化型甲状腺癌^(131)I治疗随访中的应用 被引量:3

The Application of ^(131)I-and ^(99m)Tc-MIBI Whole Body Scan Combined Determination with Serum Thyroglobulin and CEA Levels in the Follow-up of Differentiated Thyroid Carcinoma with ^(131)I Radiotherapy
下载PDF
导出
摘要 目的:评价131I-WBS和99mTc-MIBI全身显像联合血清Tg和CEA检测在分化型甲状腺癌术后放射性131I治疗随访中的应用价值。方法:48例DTC患者均行手术治疗并经131I治疗后(3~6)个月随访复查131I-WBS和血清Tg和CEA测定,131I-WBS显像阴性者于治疗后1年行99mTc-MIBI全身显像。结果:48例DTC患者行131I治疗后定期随访显示,35例患者的血清Tg水平及131I全身显象(131I-WBS)均为阴性,6例患者的血清Tg水平和131I-WBS均为阳性,两者符合率为85.42%(41/48);5例患者血清Tg水平为阳性而131I-WBS显像为阴性;2例患者血清Tg水平为阴性而131I-WBS显像为阳性。40例131I-WBS阴性者中99mTc-MIBI全身显像均为阴性。48例患者中仅2例血清CEA水平阳性。结论:131I-WBS显像联合血清Tg测定是检测甲状腺癌复发或转移最常用的方法,而99mTc-MIBI全身显像和血清CEA测定可作为131I-WBS和血清Tg测定有益的补充。 Objective To evaluate the value of 131I-and 99mTc-MIBI whole body scan combined determination with serum thyroglobulin and CEA levels in the follow-up of differentiated thyroid carcinoma with131I radiotherapy after surgical treatment.Methods Fourty eight patients with DTC after surgical treatment were treated with 131I radiotherapy.131I-whole body scan combined determination with serum thyroglobulin,CEA levels were performed three to six months after 131I radiotherapy.While 99mTc-MIBI whole body scan was performed one year after treatment when 131I-whole body scan was negative.Results Regular follow-up after 131I treatment in 48 patients showed that 35 cases were found negative with 131I-WBS and serum Tg level while 6 cases were proved positive in both methods,and 5 cases were negative in 131I-WBS with positive serumTg level,on the other hand,2 cases were positive in 131I-WBS with negative serum Tg level.40 cases of 131I-WBS negative patients in the 99mTc-MIBI whole body scintigraphy were also negative.In 48 patients only 2 cases had positive serum CEA level.Conclusion 131I-whole body scan combined with serum Tg level determination were the most commonly method in the detecting of a recurrent or metastatic thyroid cancer,and 99mTc-MIBI whole body scan and serum CEA level may become a useful supplement to 131I whole body scan and serum Tg level determination.
出处 《放射免疫学杂志》 CAS 2011年第6期604-606,共3页 Journal of Radioimmanology
关键词 甲状腺癌131碘 甲状腺球蛋白(Tg) 131I-全身显像 99m Tc-甲氧基异丁基异腈 癌胚抗原 (CEA) thyroid carcinoma 131I Tg 131I-WBS 99mTc-MIBI CEA(carcinoembryonic antigen)
  • 相关文献

参考文献11

  • 1Cooper DS,Doherty GM,Haugen BR,et al.Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid,2009,19:1167-1214.
  • 2Allan H,Clive H,Ujjal M,et al.REVIEW:131I Activity for remnant ablation in patients with differentiated thyroid cancer:A systematic review[J].J Clin Endocrinology and Metabolism,2007,92(1):28-38.
  • 3Schlumberger MJ.Medical progress:papillary and follicular thyroid carcinoma[J].N Engl J Med,1998,338:297-306.
  • 4Phan HT,Jager PL,Van der wal JE,et al.The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation[J].Euro J Endocrinology,2008,158(1):77-83.
  • 5Mazzaferri EI,Robbins RJ,Spencer CA,et al.A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma[J].J Clin Endo Metab,2003,8(4):1433-1441.
  • 6戴庆靖,匡安仁.甲状腺球蛋白测定的临床意义及影响因素[J].同位素,2007,20(2):120-124. 被引量:21
  • 7Park HM,Perkins OW,Edmondson JW,et al.Influence of diagnostic radioiodines on the uptake of ablative doses of iodine-131[J].Thyroid,1994,4(1):49-54.
  • 8王全林,于南.诊断剂量的^(131)碘全身显像后甲状腺组织顿抑效应的评价[J].川北医学院学报,2001,16(1):45-47. 被引量:3
  • 9Van Dijk D,Plukker JT,Van der Horst-Schrivers AN,et al.The value of detectable thyroglobulin in patients with differentiated thyroid cancer after initial 131I therapy[J].Clin Endocrinol,2011,74(1):104–110.
  • 10Masahiro Iwata,Kanji Kasagi,Takashi Misaki,et al.Comparison of whole-body 18F-FDG PET,99mTc-MIBI SPET,and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer[J].Euro J Nuclear Med and Molecular Imaging,2004,31(4):491-498.

二级参考文献37

  • 1SCHLUMBERGER M.Follow-up of Patients With Differentiated Thyroid Cancer[C]// Johnson JT,Didolkar MS.Head and Neck Cancer.Amsterdam:Elsevier Science Publishers,1993:903.
  • 2HARMER CL.Thyroid Cancer[C]// Oncology HA.A Multidisciplinary Textbook.London:Chapman and Hall,1995:565-584.
  • 3EICHHORN W,TABLER H,LIPPOLD R,et al.Prognostic Factors Determining Long-term Survival in Well-differentiated Thyroid Cancer:an Analysis of Four Hundred Eighty-four Patients Undergoing Therapy and Aftercare at the Same Institution[J].Thyroid,2003,13:994-958.
  • 4SPENCER CA.Clinical Utility of Serum Thyroglobulin Measurement,Current Opinion in Endocrinology & Diabetes[J].Lippincott Williams & Wilkins,2002,9(5):401-406.
  • 5KNUDSEN N,BULOW I.Serum Tg-a Sensitive Marker of Thyroid Abnormalities and Iodine Deficiency in Epidemiological Studies[J].J Clin Endocrinol Metab,2001,86(8):3 599-3 603.
  • 6CATUREGLI P,MARIOTTI S,KUPPERS RC,et al.Epitopes on Thyroglobulin:a Study of Patients With Thyroid Disease[J].Autoimmunity,1994,18:41-49.
  • 7PRENTICE L,KISO Y,FUKUMA N,et al.Monoclonal Thyroglobulin Autoantibodies Variable Region Analysis and Epitope Recognition[J].J Clin Endocrinol Metab,1995,80:977-986.
  • 8SPENCER CA,WANG CC.Thyroglobulin Measurement:Techniques,Clinical Benefits and Pitfall[J].Endocrinol Metab Clin North Am,1996,24:841-864.
  • 9FELDT-RASMUSSEN U,PROFILIS C,COLINET E,et al.Purification and Assessment of Stability and Homogeneity of Human Thyroglobulin Reference Material (CRM457)[J].Exp Clin Endocrinol,1994,102:87.
  • 10SPENCER CA.Assay of Thyroid Hormones and Related Substances[EB/OL],http://www.thyroidmanager.org/Function Tests/assay-frame.htm,2004-02-06.

共引文献22

同被引文献11

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部